All In Biotech

Drug Trial Radar · NCT00254163

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

A Prospective, Randomized, Open Label, Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-cell Chronic Lymphocytic Leukemia

Last checked: Nov 19, 2026Latest source record: Nov 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

184

Actual

Start

Dec 2003

Primary completion

Sep 2011

Study completion Sep 2011

Sponsor

Lead sponsor
US Oncology ResearchIndustry
Sponsor type
Industry
Collaborators
Astex Pharmaceuticals, Inc.
First posted
Nov 15, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to find out what effects (good and bad) the combination of Nipent+Cytoxan+Rituxan has on CLL cancer compared to Fludara+Cytoxan+Rituxan. While all of these drugs are approved by the Food and Drug Administration (FDA) for the treatment of other cancers, these combinations are experimental for the treatment of CLL.

Conditions

  • B-Cell Chronic Lymphocytic Leukemia

Interventions

  • FludarabineDrug

  • CyclophosphamideDrug

  • RituximabDrug

  • PentostatinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infection RateTime frame: 6 cycles of 28-day for FCR and 8 cycles of 21-day for PCR, or until PD, CR, or intolerable toxicity

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Cancer Centers of Florida, P.A.

    Ocoee, Florida

  • Hope Center

    Terre Haute, Indiana

  • Alliance Hematology Oncology PA

    Westminster, Maryland

  • St Joseph Oncology, Inc

    Saint Joseph, Missouri

  • New York Oncology Hematology, PC

    Albany, New York

  • Northwestern Carolina Oncology Hemato

    Hickory, North Carolina

  • Medical Oncology Associates

    Kingston, Pennsylvania

  • South Texas Cancer Center-McAllen

    McAllen, Texas

  • Texas Oncology Cancer Center-Sugar Land

    Sugar Land, Texas

  • Cancer Care Northwest-South

    Spokane, Washington

  • Yakima Valley Mem Hosp/North Star Lodge

    Yakima, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.